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2Abstract
Viruses carry nucleic acids between and within host cells.  Invariably, virus 
attachment to host cells leads to activation of cell signalling.  These so-called forward 
signals emerge from interactions with cell surface receptors or cytosolic proteins and 
elicit profound responses in the cells, for example induction of growth or innate 
immunity responses.  They can enhance or suppress infection.  In addition, viruses 
receive signals  from the cell.  These reverse signals  can impact on the structure of 
the virus  leading to genome uncoating.  They can enhance infection or inactivate 
virus, for example by facilitating degradation.  Here we discuss the nature and 
mechanisms by which forward and reverse signals  emerge and affect the outcome of 
human adenovirus  infections.  We describe how human adenoviruses use cell 
surface receptors for forward signalling to activate cell growth, intracellular transport 
or innate immune response.  We also discuss how adenoviruses use acto-myosin, 
integrins or microtubule-based kinesin motors for reverse signalling to facilitate their 
stepwise uncoating program.  
 
3Introduction
Viruses are diverse in nature and appearance.  They range from small non-enveloped 
single stranded RNA or DNA viruses to lipid bearing double stranded RNA or DNA 
viruses with haploid or diploid genomes.  Despite large diversity, they share common 
principles enabling infection.  One invariable feature is that they protect their genome 
with a proteinaceous capsid and sometimes a lipid envelope.  Capsid or envelope 
proteins dock to cellular receptors or soluble proteins.  Another conserved feature 
between viruses  is that they activate cell-signalling processes as soon as they 
interact with cells.  In some cases this  leads to the stimulation of endocytic uptake 
processes, such as clathrin-mediated endocytosis or macropinocytosis (Gastaldelli et 
al., 2008, Amstutz et al., 2008, Mercer et al., 2009), the interference with the cell cycle 
or induction of cancer (Damania, 2007).  Many aspects of adenovirus (AdV) biology 
have been intensively studied, and rapid progress  occurs  in areas of virus structure 
and entry, replication, pathology and immunology, evolution, vector development and 
vaccinations (recently reviewed in Greber et al., 2012).  Here we discuss  how human 
adenoviruses (HAdV) induce signalling to the cell during entry, and how the viruses 
receive signals from the cell by a reverse process.
Forward signalling from cell surface receptors
Cell surface receptors mediate initial contacts of viruses to cells, and this can trigger 
cell signalling.  If virus-receptor interactions are of high affinity, a few hundred 
receptor molecules per cell are sufficient for infection.  If the interactions  are of low 
affinity (in the micro-molar or even milli-molar range), or if the binding site on the 
receptor is  masked, increased numbers of receptors are required for virus 
attachment.  This  can occur through avidity binding.  Viruses are able to use avidity 
binding since they often display multiple receptor binding sites in close spatial 
proximity.  In the case of HAdVs, this has been demonstrated for binding of HAdV-3/7 
to the membrane cofactor CD46 (Trinh et al., 2012).  Furthermore, C-species HAdV 
4(HAdV-C) also bind with a large spectrum of affinities to their receptor, the 
coxsackievirus adenovirus receptor (CAR) (Kirby et al., 2001).  Low affinity, high 
avidity binding allows viruses to use multiple receptors depending on receptor 
availability, and this may broaden virus tropism.  In the following section, we discuss 
the current picture of attachment factors, entry receptors, and supporting bridging 
factors for HAdV infections (for an overview, see Fig. 1). 
The coxsackievirus adenovirus receptor CAR
AdV were first isolated in the 1950s (Rowe et al., 1953).  However, the identification 
of the first AdV receptor (CAR) took more than 40 years (Bergelson et al., 1997, 
Tomko et al., 1997).  CAR is involved in the formation of tight and adherens junctions 
between epithelial cells  (Cohen et al., 2001, Walters  et al., 2002).  It belongs to the 
immunoglobulin superfamily and is  expressed in heart, brain, pancreas, intestine and 
at low levels in liver and lung (Fechner et al., 1999).  CAR interacts with the fiber 
knobs from HAdV of all species, except those from species HAdV-B (Roelvink et al., 
1998).  Interestingly, the HAdV fibers bind to the same extracellular domain of CAR 
(the D1 domain), which is  also engaged in homophilic CAR-CAR contacts  between 
neighbouring cells, however, with much higher affinity (Bewley et al., 1999, Freimuth 
et al., 1999).  In contrast to CAR dimerization, the attachment of viruses to CAR has 
been reported to elicit intracellular signalling that leads to an inflammatory response 
and expression of cytokines  in human respiratory cells (Tamanini et al., 2006).  In 
addition, CAR overexpression studies in epithelial cells suggested that CAR is directly 
or indirectly involved in the activation of p42/44 extracellular receptor kinases (ERK) 
and could enhance β1/3 integrin expression (Farmer et al., 2009).  The cytoplasmic 
domain of CAR appears to be involved in ERK activation (Farmer et al., 2009), but 
can be dispensable for HAdV cell entry (Wang et al., 1999, Burckhardt et al., 2011). 
This  is consistent with chemical interference studies showing that ERK signalling is 
not required for virus entry but rather plays  a critical role in the inflammatory process 
5triggered by the virus (Bruder et al., 1997, Suomalainen et al., 2001, Smith et al., 
2011).  
The membrane cofactor CD46
How HAdV-B species  bind to blood and epithelial cells has remained unknown until 
recently.  In 2003/04, four groups reported that the membrane cofactor CD46 was 
required for binding of HAdV-3, 11, 16, 21, 35, 50 (species HAdV-B1 and B2), as well 
as HAdV-37 (species HAdV-D) to epithelial and hematopoietic cells (Gaggar et al., 
2003, Segerman et al., 2003, Sirena et al., 2004, Wu et al., 2004).  More recently, 
HAdV-26 and 49 (species HAdV-D) were also found to use CD46 as a receptor 
(Lemckert et al., 2006, Li et al., 2012).  These studies showed that all HAdV-B attach 
to cells  via their fiber knobs, which recognize the extracellular domain of CD46, albeit 
with different affinities (Pache et al., 2008, Cupelli et al., 2010).  This  was concluded 
from a variety of biochemical and cell biological experiments  and infection assays, 
including cDNA expression in receptor-negative non-human cells, virus-receptor co-
localizations at the ultra-structural level, in-solution binding assays, mass 
spectrometry, antibody inhibitions of cell binding and infection, competition 
experiments with soluble fiber or receptor domains, or RNA interference in cultured or 
primary cells.  CD46 is expressed on all nucleated cells in humans, and shields 
autologous cells from complement attack (for a review, see Riley-Vargas et al., 2004).  
Interestingly, ligand-induced CD46-oligomerization triggers macropinocytosis and 
down-regulation of CD46 (Crimeen-Irwin et al., 2003), which in turn increases 
immune suppression and complement-mediated lysis.  HAdV-3/35 (HAdV-B species) 
use CD46 for infection, and they enter and infect epithelial and hematopoietic cells  by 
triggering macropinocytosis (for an overview of the pathway, see Fig. 2, and Amstutz 
et al., 2008, Kalin et al., 2010).  These viruses also use the C-terminal binding protein 
1 of E1A (CtBP1), which is a phosphorylation target of p21-activated kinase (PAK) 1. 
6CtBP1 is a multifunctional protein involved in transcriptional repression and 
membrane trafficking, including PAK1-mediated macropinocytosis (Liberali et al., 
2008).  HAdV-3 entry activates PAK1 through Rac1, and both PAK1 and Rac1 are 
required for HAdV-3 or 35 infections (Amstutz et al., 2008, Kalin et al., 2010). 
Macropinosomes positive for fluorescent fluid phase marker dextran contain viruses 
and CD46, αv integrin, CtBP1 and PAK1.  Collectively, the data show that HAdV-B 
bind to CD46 and induce an endocytic pathway, which is used in antigen presentation 
and cell migration in non-polarized cells.  The HAdV-B entry pathway may modulate 
immune responses possibly by interference with the transcriptional co-repressor 
CtBP1.  Whether CD46 has a receptor function for HAdV-B on polarized cells lining 
tissue epithelia has not been reported so far.  
The cell adhesion molecule desmoglein 2
Based on cross-competition data between HAdV-B types in different cells and 
neutralizations of infections with fiber knobs, it was  widely assumed that there are 
additional attachment receptors for HAdV-B species, besides CD46.  Using blot 
overlay techniques on SDS-denatured gel fractionated extracts from receptor positive 
and negative cells in combination with mass spectrometry, desmoglein-2 (DSG-2) 
was identified as an attachment receptor for HAdV-3, 7, 11, 14 (Wang et al., 2011). 
DSG-2 belongs to the cadherin family of calcium-binding trans-membrane 
glycoproteins and is a component of the adhesion complexes between epithelial cells. 
The affinities of fibers to DSG-2 are weak, as the trimeric fiber knob from HAdV-3 did 
not bind to DSG-2, unlike intact HAdV-3 or penton-fiber complexes, so called 
dodecahedrons.  This was similar to CD46, which bound to HAdV-3 or 
dodecahedrons by an avidity mechanism (Sirena et al., 2004, Trinh et al., 2012).  
Intriguingly, the binding of AdV or dodecadehrons to DSG-2 elicited events  similar to 
epithelial-to-mesenchymal transition (EMT), as evidenced by marker profiling and 
7p42/44-ERK or phosphatidyl-inositol-3 kinase phosphorylations (Wang et al., 2011). 
Virus-induced EMT apparently opened up intercellular junctions.  In the context of an 
epithelium, this could lead to the exposure of basolateral receptors  towards the 
luminal side, for example the airway lumen, and thereby enhance the accessibility of 
the epithelium to exogenous agents  and enhance infection.  This is reminiscent of 
earlier reports showing that the release of excess fiber proteins from AdV infected 
cells disrupted cell-cell contacts and promoted the release of newly synthesized 
viruses from epithelia (Walters et al., 2002).   
Sialic acid and bridging factors
Highly abundant structures in glycoproteins  or glycolipids of the cell surface are the 
negatively charged sialic acids.  HAdV-8, 19, 37 (species HAdV-D) contain positive 
charges in their fiber knobs and bind sialic acid (Nilsson et al., 2011).  These 
interactions, however, do not account for the ocular tropism of species HAdV-D, since 
sialic acid is not specific for cell of the conjunctiva.  Possibly, virus interactions with 
sialic acid contribute to AdV hemagglutinations, given that the erythrocyte surface is 
rich in the sialic acid bearing glycophorin A.  It is also possible that virus attachment to 
sialic acid enhances the binding to other low affinity attachment sites, from which 
signals are transduced to the host cell.  
Other low affinity attachment sites for AdV are heparan sulfate containing 
proteoglycans (HSPG) of the extracellular matrix.  They comprise trans-membrane 
syndecans and glycosyl-phosphoinositide-linked glypicans.  HSPG were reported to 
bind the fiber shaft of HAdV-C through a lysine-lysine-threonine-lysine (KKTK) motive 
(Dechecchi et al., 2001, Darr et al., 2009).  Recently, HSPG was suggested as an 
attachment site for mouse AdV-1 on endothelial cells (Lenaerts et al., 2012), and for 
assisting HAdV-3 attachment to integrin (Tuve et al., 2008, Gout et al., 2010).  The 
precise role of HSPG in AdV infection remains elusive, however, also because the 
8affinity of AdV to HSPG is  apparently much lower than of Herpes virus type 1 (Shukla 
et al., 1999, Kalin et al., 2010).  Accordingly, little information exists  for potential 
signalling events from bridging factors in HAdV entry.  For further information on 
coagulation factor X, lung surfactant di-palmitoyl-phosphatidylcholine or lactoferrin, 
the reader is referred to Fig. 1, and a review (Arnberg, 2009). 
Integrins as signalling receptors
Integrins are adhesion receptors, consisting of an α and β subunit, and connect cells 
to the extracellular matrix (ECM).  They transduce outside-in or inside-out signals, 
and regulate cell survival and migration.  Integrins  were discovered as an AdV 
receptor long before CAR was known.  An initial key observation was that soluble 
penton base from HAdV-2 precluded the attachment of αv integrin-positive cells to 
culture dishes (Wickham  et al., 1993).  Soluble penton base did not interfere with 
virus attachment to cells but inhibited virus endocytosis, similar to soluble RGD 
(arginine-glycine-aspartate) peptides, a motif also present in penton base.  The RGD 
motive is  found in all HAdV penton bases, except HAdV-40/41 (species HAdV-F), 
allowing these viruses to use αvβ1, αvβ3, αvβ5, α3β1 or αMβ2 integrins  depending on the 
cell type (reviewed in Stewart et al., 2007).  
The best-characterized integrins in HAdV entry are αvβ3 and αvβ5 expressed on many 
epithelial cells (for a schematic drawing, see Fig. 3A).  Both of them promote virus 
internalization, depending on the penton base RGD or an engineered RGD in the 
fiber knob (Wickham et al., 1993, Nagel et al., 2003).  This suggests that HAdV use 
integrins that are in an activated state, and transduce signals, for example to 
phosphatidylinositol-3-OH kinase (PI3K) (Li et al., 1998b).  Lipid products of PI3K can 
activate the small GTP-binding proteins RhoA, Rac1 and Cdc42 and lead to actin 
remodelling, which is important for viral endocytosis (Li et al., 1998a).  These data 
9suggest a positive feedback loop between integrins, PI3K and actin to promote virus 
uptake (Fig. 3A).  
The uptake of HAdV-2/5 is controlled by the large GTPase dynamin (Wang et al., 
1998, Meier et al., 2002, Gastaldelli et al., 2008).  Recent proteomics analyses have 
shown that HAdV-5 entry leads to S-nitrosylation of dynamin-2 at cysteine residues 
C86 and C607, and that the overexpression of S-nitrosylation-resistant C86A or 
C607A dynamin mutants  reduces HAdV infection (Wang et al., 2012).  S-nitrosylation 
is  likely mediated by eNOS (endothelial nitric oxid synthase), which gets activated by 
denitrosylation and phosphorylation upon HAdV-5 entry (Fig. 3A).  It remains 
unknown, however, how HAdV activates eNOS and increases nitric oxide (NO) in 
epithelial cells.  
Signalling to increase receptor availability
The respiratory, digestive, urogenital and ocular tracts are major portals of entry for 
viruses into vertebrates.  Polarized epithelial cells provide the borders for tissues, 
typically with their apical plasma membrane facing the outside.  Intriguingly, many 
receptors for viruses are not localized on the apical membrane, but at the basal and 
lateral membranes.  This  renders polarized cells  resistant against infections, for 
example by HSV-1, poliovirus, reovirus or HAdV (Greber et al., 2007, Bergelson, 
2009).  The reason why these viruses have no apical receptors is  unclear.  One can 
speculate that it is  due to protection of the apical membrane by a mucus layer, which 
precludes the accessibility of the apical plasma membrane to agents in the lumen of 
the respiratory tracts, for example.  
HAdVs invade the lumen of the digestive and respiratory tracts.  Their receptors  CAR, 
DSG-2 and integrins are localized at the basolateral membranes.  In the airway 
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lumen, alveolar macrophages engulf incoming viruses.  This triggers the release of 
chemotactic and pro- and anti-inflammatory cytokines  (Zsengeller et al., 2000, 
Higginbotham et al., 2002).  The released cytokines include junction-remodelling 
factors, such as interferon (IFN) γ and tissue necrosis  factor alpha (TNF-α). 
Junctional remodelling by cytokines may facilitate the passage of activated immune 
cells across the epithelial border (Zen et al., 2005).   
A recent study has  shown that human blood derived macrophages inoculated with 
HAdV-2 release IFN-γ, TNF-α or interleukin 6 (IL-6), and also the chemokine IL-8 
(Lutschg et al., 2011).  When polarized epithelial airway cells were co-cultured with 
macrophages, they become susceptible to apical HAdV-2.  Susceptibility depends to 
a large extent on IL-8 released from the macrophages.  The treatment of polarized 
epithelial cells with IL-8 was sufficient to induce the expression of CAR and αvβ3 
integrins on the apical surface, while IFN-γ had no effects (see Fig. 3A).  This 
suggests that CAR and αvβ3 integrins are associated with cell migration and immune 
signalling.  IL-8 strongly enhanced apical infection of polarized cells  by signalling 
through the G-protein coupled chemokine receptors CXCR1/2, thereby activating the 
non-receptor tyrosine kinase Src and the adaptor paxillin.  The observation that CAR, 
which normally engages in homophilic contacts between neighbouring cells, 
delocalized to the apical membrane under inflammatory conditions suggests that it 
directly or indirectly coordinates inflammatory responses (Verdino et al., 2010).  One 
can speculate that those HAdV, which elicit low levels of inflammatory responses, are 
less dependent on cytokines for epithelial infections.  These viruses might have found 
ways to infect epithelial cells by using apical attachment factors, such as CD46, 
particular lipids, sugars or bridging factors (see also Fig. 1).  
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Reverse signalling
Virus entry involves a two-way dialogue between the virus and the cell, and 
comprises forward signalling from the virus to the cell and reverse signalling from the 
cell to the virus.  Already, directly upon AdV attachment to the cell, the particle starts 
moving on the cell surface.  These CAR-dependent motions comprise rapid diffusive 
motions and steady acto-myosin-dependent drifts (Burckhardt et al., 2011).  The drifts 
are based on actin filaments  moving retrograde from the periphery to the cell body. 
They are driven by actin polymerisation at the periphery and pulling forces from 
myosin-2 (for a review, see Burckhardt et al., 2009).  
The drifting motions of CAR are of key importance for triggering initial steps of the 
stepwise virus-uncoating program, which starts with the release of the fibers from the 
virus (Fig. 3B, upper panel).  This is assisted by another reverse signal, the binding of 
αvβ3/5 integrins to the virus  penton base (Burckhardt et al., 2011).  Unlike CAR, 
integrins are static receptors and their motions at the surface are confined.  If CAR-
induced movements  and integrin-induced confinements occur simultaneously at one 
virus particle, the resulting force on the virus might contribute to loosening the virus 
structure.  This loosening could be enhanced by the interaction of the RGD-loops 
from penton base with integrins.  The latter lead to a clockwise rotation of the penton 
base pentamer (Lindert et al., 2009).  These opposed forces applied to the virus at 
the cell surface also enable the exposure of protein VI from the inside of the virus. 
During later steps of infection this can enhance the hydrophobic surface of the virus 
to break open the limiting endosomal membrane (Wiethoff et al., 2005, Burckhardt et 
al., 2011).  
Upon endosomal escape, the AdV particle is transported via dynein along 
microtubules towards the perinuclear region. This process was recently reviewed 
(Dodding et al., 2011, Scherer et al., 2011).  Another event of reverse signalling 
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occurs at one of the last steps of the HAdV-2/5 uncoating program, the disruption of 
the capsid and the dissociation of the viral DNA from the capsid (see Fig. 3B, lower 
panel).  This takes place at the nuclear pore complex (NPC) (Trotman et al., 2001), 
and requires the microtubule motor Kif5C (Strunze et al., 2011).  Upon docking at the 
nucleoporin (Nup) 214, the virus recruits conventional kinesin by binding to the Kif5C 
light chain Klc1/2 (Strunze et al., 2011).  The heavy chain is pre-attached to Nup358 
at the NPC.  Kif5C binding to Nup358 stabilizes the open conformation and leads  to 
allosteric motor activation (Cho et al., 2009).  For virus disruption, Kif5C is thought to 
exert a force on the capsid against a holding force from the NPC.  This  leads  to the 
separation of the viral DNA from the capsid, and kinesin motors and virus capsid 
fragments move from the NPC to the cell periphery (Strunze et al., 2011).  Now the 
DNA in association with protein VII but not protein V can be imported into the nucleus, 
which involves nuclear import factors, such as transportin, importin beta and importin 
7 (Trotman et al., 2001, Hindley et al., 2007).  This is an example for a direct back-
signalling process from the cell to the virus with consequences for virus and NPC 
integrity.  It ensures that the uncoated DNA can readily access the nuclear 
translocation machinery.  We anticipate that other back-signalling events take place 
on endosomal or cytosolic AdV particles, and possibly also non-related viruses. 
Conclusions and outlook to signalling for innate responses
It has been well established that incoming HAdV trigger signal transduction pathways 
leading to cell activation and innate immunity.  The latter processes are less  well 
characterized than the cell activation signals (Fejer et al., 2011).  For example, 
binding of the HAdV-5 fiber to CAR on epithelial cells leads to NFκB activation and 
enhances the transcription of the chemokines IL-8, GRO-α, GRO-γ or RANTES 
(Tamanini et al., 2006).  p42/44-ERK or p38 mitogen-activated protein kinase appear 
not to be involved, but HAdV DNA and particular sequence motifs therein are 
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decoded in endosomes by Toll-like receptor 9 (TLR9) leading to innate signalling 
(Iacobelli-Martinez et al., 2007, Perreau et al., 2012).  
The rupture of endosomal membranes and residence of viruses  in the cytosol also 
contribute to innate immunity signalling.  This was suggested from experiments with 
the HAdV-2 mutant ts1, which is  unable to break endosomal membranes and 
therefore cannot reach the cytosol (Tibbles et al., 2002, Imelli et al., 2009, Smith et 
al., 2011, Maier et al., 2012).  Various cytosolic sensors have been implicated in 
innate signalling during AdV entry (Fejer et al., 2008).  The nucleotide oligomerization 
domain (NOD)-like receptor (NLR) containing pyrin domain 3 (NLRP3) triggers an 
inflammasome-dependent response, leading to activation of the IL-1 receptor, NFκB 
and chemokine release (Barlan et al., 2011).  Furthermore, NOD2, another NLR 
exclusively expressed in monocytes, macrophages, dendritic cells, and intestinal 
Paneth cells were shown to be involved in innate immune response to HAdV vectors 
(McDermott et al., 2007, Suzuki et al., 2011).  In a previous study it was already 
demonstrated that NOD2 responds  to single strand RNA (Sabbah et al., 2009). 
Absent In Melanoma (AIM) 2 and the helicase DDX41 are involved in activation of the 
IFN response factor 3 (Stein et al., 2012).  To antagonize an anti-viral state, the 
immediate early trans-activator E1A of HAdV-5 binds to and dissociates the hBre1/
RNF20 ubiquitin ligase complex, thus inhibiting mono-ubiquitination and inducing the 
suppression of interferon-stimulated genes (Fonseca et al., 2012).  It will now be 
interesting to investigate, how modulations of host anti-virus responses are integrated 
in the overall host transcriptional response to HAdV infections.  This may lead to a 
better understanding of both anti- and pro-viral host response pathways.  
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Legends to figures
Fig. 1: Summary of HAdV entry receptors, attachment- and bridging factors and 
tropism.  
Additional information and literature can be found in the main text. 
Fig. 2: Signalling events during HAdV-B entry into non-polarized epithelial or 
hematopoietic cells.
Binding of HAdV-3/35 to its receptors CD46 and αvβ3/5 integrins  leads  to the 
activation of Rac1, which is involved in actin remodelling and results in membrane 
curvatures termed ‘wobbling’ (Amstutz et al., 2008, Kalin et al., 2010).  Furthermore, 
Pak1 and CtBP1 are activated in a Rac1 dependent way by HAdV-B, and lead to 
macropinocytosis.  The virus-containing macropinosomes are positive for Pak1 and 
CtBP1.  Possibly, this entry pathway interferes  with innate immunity responses 
through the transcriptional co-repressor CtBP1.
Fig. 3: Forward and reverse signalling in cell entry of HAdV.
A. Forward signalling and receptor accessibility.  
HAdV-2/5 can be taken up by macrophages that ‘patrol’ on the apical side of 
polarized epithelial cells.  This leads to the secretion of various cytokines  including 
interleukin 8 (IL8).  IL8 binds  to the CXCR1/2 receptor and triggers  the 
phosphorylation (P) of the non-receptor tyrosine kinase Src and the adaptor paxillin. 
These proteins are involved in relocating CAR and integrins from the basal to the 
apical surface and thus enable virus attachment and infection from the apical plasma 
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membrane (Lutschg et al., 2011).  The binding of HAdV-2/5 to integrins leads to 
numerous intracellular signals, including PI3K and the actin remodelling GTPases 
RhoA, Cdc42 and Rac, and promote virus endocytosis (see main text).  HAdV-2/5 
endocytosis is  controlled by dynamin-2 (Dyn2), which gets S-nitrosylated (NO) most 
likely by the endothelial nitric oxid synthase (eNOS) (Wang et al., 2012).  This 
pathway leads to infection.
B. Reverse signalling. 
Reverse signals from the cell to the virus emerge for example, when myosin2 and 
actin-dependant movements of CAR are attenuated by immobile integrins.  This 
creates a force on the virus, and leads to loosening of the capsid structure, as 
measured by the loss of fibers (upper part) (Burckhardt et al., 2011).  Additional 
reverse signals from the cell to the virus  may come from cytoplasmic motors, such as 
dynein/dynactin and result in displacement of the cytosolic virus towards the nucleus. 
We do not show these events, since they have been covered in recent reviews 
(Greber et al., 2006, Dodding et al., 2011, Scherer et al., 2011).  During later steps of 
infection the virus docks to the nuclear pore complex (NPC) by interacting with the 
nucleoporin (Nup) 214, and subsequently binds to the light chain (Klc1/2) of the 
conventional kinesin Kif5C (Strunze et al., 2011).  The movement of the motor 
towards the microtubule plus end occurs against a holding force from the NPC, and 
leads to the disruption of the capsid and in part the NPC.  This facilitates the release 
of the viral DNA into the nucleus (lower part).  
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